no thats fine. You can use this opportunity to explain how your product is DSHEA compliant and wont result in the FDA charging someone with marketing an adulterated product / unapproved new drug?
i know of no evidence that exogenous systemic mgf would blunt the production of mgf in the muscle. exogenous mgf has barely even been studied to begin with
yes mgf is produced locally and acts locally (it is an autocrine hormone).
mgf (or any other substance for that matter) cannot...
I concur that localized use (most specifically for connective tissue and other areas of poor blood supply) is probably to best utilization of IGF-1 - especially longR3 IGF-1. It really is not a good choice for a whole body anabolic agent as it is quite non-specific for muscle and also can be...
It is incorrect that IGF-bound to BP3 is useless. In fact that opposite is true. BP3 protects the IGF-1 from rapid metabolism and so extends its half life greatly. the complex delivers IGF-1 to target tissues where enzymes cleave it.
As a matter of fact a IGF-1 BP3 complex was patented...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.